Pharmacology and toxicology of an oral tablet whole cells inactivated cholera vaccine in Sprague Dawley rats

Vaccine

Volumn 29, Issue 19, 2011, Pages 3596-3599

  López, Yulieé ^a   Infante, Juan Francisco ^a   Sifontes, Sergio ^a   Díaz, Daiyana ^a   Pérez, Viviana ^a   Año, Gemma ^a   Hernández, Tamara ^a   Fernández, Sonsire ^a   Castaño, Jorge Luis ^b   Cedré, Bárbara ^a   Oliva, Reynaldo ^a   García, Luis ^a   Solís, Rosa L ^a   Talavera, Arturo ^a  

^a FINLAY INSTITUTE   (Cuba)

^b MEDSOL Laboratories   (Cuba)

Author keywords

Cholera; Inactivated vaccine; Pharmacology; Sprague Dawley rats; Tablets; Toxicity

Indexed keywords

BACTERIUM ANTIBODY; CHOLERA VACCINE; INACTIVATED VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BIOCHEMISTRY; BIOLOGICAL ACTIVITY; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; ENTERIC COATED TABLET; FEMALE; FLUID INTAKE; FOOD INTAKE; HEMATOLOGY; MALE; NONHUMAN; PHARMACOLOGY; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TOXICOLOGY; VIBRIO CHOLERAE; WHOLE CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA; CHOLERA VACCINES; FEMALE; IMMUNIZATION; MALE; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TABLETS; VACCINES, INACTIVATED; VIBRIO CHOLERAE;

EID: 79955023768     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.074     Document Type: Article

References (24)

1. Word Health Organization. WHO. Weekly Epidemiological Record, No. 31; 4 August 2006.
2. Talavera A., Pérez E.M. Is cholera disease associated with poverty?. J Infect Dev Ctries 2009, 3(6):408-411.
3. Walter R.I. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 2005, 23:3369-3385.
4. Anha D.D, Canha D.G., Lopez A.L., Thiema V.D., Longc P.T., Sona N.H., et al. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine 2007, 25:1149-1155.
5. Word Health Organization. Nonclinical evaluation. Available from: http://www.who.int/biologicals/areas/vaccines/nonclinical_evaluation/en/index.html.
6. Word Health Organization. Guidelines for the production and control of inactivated oral cholera vaccines. WHO Technical Report, Series No. 924; 2004.
7. Proceedings of the workshop on non-clinical safety evaluation of preventive vaccines: recent advances and regulatory considerations, vol. I, Monday, December 2, 2002, Arlington, Virginia. Miller Reporting Co., Inc., 735 8th Street, S.E. Washington, DC 20003-2802, (202) 546-6666.
8. Sifontes S., Infante J.F., López Y., Fariñas M., Claveras A., Sosa E., et al. Toxicity study per repeated dose of the V. cholerae attenuated vaccine in Sprague Dawley rats. Arch Med Res 2009, 40(7):527-535.
9. Talavera A., Año G., Pino Y., Castaño J., Uribarri E., Riverón L., et al. Formulation in tablets of a cholera whole cells inactivated vaccine candidate. Vaccine 2006, 24:3381-3387.
10. Cedré B., García H., García L., Talavera A. Estandarización del ensayo Vibriocida modificado para la determinación de anticuerpos contra Vibrio cholerae. Rev Cubana Med Trop 1999, 51(3):56-59.
11. Infante J.F., Sifontes S., Álvarez E., González M., Pérez V., Sosa E., et al. Toxicity study per single dose of vax-SPIRAL vaccine in Sprague Dawley rats. Vacci Monitor 2004, 13(2):11-15.
12. Canadian Council on Animal Care and Use Laboratory rats. Guide to the care and use of experimental animals 1993, vol. 2:175-187. Canadian Council on Animal Care and Use, Ottawa, Ontario, [chapter XXI].
13. Pérez G.R.M., Montalvo D.M., Rodríguez A.J.C., Calderón M.C.F., Cruz M.J., Bello G.J.L. Determination of toxicity in reiterative dose of the arsenical. Oncol Cuban Mag 2001, 17(2):111-117.
14. Sincharoen Kul R., Chaicumpa W., Pongponratn E., Limpanonont J., Tapchaisri P., Chogsa-Nguan M. Localization of Vibrio Cholerae 01 in the intestinal tissue. Asia Pac J Allergy Immunol 1993, 11(2):155-165.
15. Abraham P., Kanakasabapathy I., Dian B.J. Propylthiouracil attenuates acetaminophen-induced renal damage in the rat. Nephrology 2005, 10:588-593.
16. Senthilkumar S., Devaki T., Manohar B.M., Babu M.S. Effect of squalene on cyclophosphamide-induced toxicity. Clin Chem Acta 2006, 364:335-342.
17. Tasduq S.A., Mondhe D.M., Gupta D.K., Baleshwar M., Johri R.K. Reversal of fibrogenic events in liver by Emblica officinalis (fruit), an Indian natural drug. Biol Pharm Bull 2005, 28:1304-1306.
18. Pritchett K.R., Coming B.F. Biology and medicine of rats. Laboratory animal medicine management 2004, International Veterinary Information Service, Ithaca NY, www.ivis.org; B 2503. 0904 (last updated: 29.11.04). J.D. Ruter, M.A. Suckow (Eds.).
19. Kkunishi H., Sudo M., Sumi M., Morii H., Minuchi T., Aimoto T., et al. Pharmacokinetic behavior of Micafungin in rats with carbon tetrachloride-induced acute hepatic failure. Biol Pharm Bull 2005, 28(3):556-559.
20. Didia B.C., Dapper D.V. Regional variation in the histological appearance of the small and large intestine of the rat following acute and chronic administration of Melo's Conguer Mixtare. West Afr J Med 1999, 18(2):110-113.
21. Infante J.F., Sifontes S., Pérez, Bracho G., Hernández T., Zayas C., et al. Immunogenicity assay and local toxicity of Neisseria meningitidis cochlear Sprague Dawley rats. Vacci Monitor 2009, 18(1):1-7.
22. Fariñas M., López Y., Infante J.F., Oliva R., Sosa E., Sifontes S., et al. Non toxicity for a single dose study and local tolerance of the vaccine against Neisseria meningitides serogruop A and C using Sprague Dawley rats. Vacci Monitor 2009, 18(2):41-42.
23. Jertborn M., Svennerholm A.M., Holmgrin J., Salina Breast milk and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol 1986, 24(2):203-209.
24. Glass R.I., Svennerholm A.M., Stoll B.J., Khan M.R., Hossain K.M., Huq M.I., et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 1983, 308-392.